Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: The OFELY study

Journal of Bone and Mineral Research

Volumn 14, Issue 9, 1999, Pages 1614-1621

  Garnero, Patrick ^a   Sornay Rendu, Elisabeth ^a   Duboeuf, François ^a   Delmas, Pierre D ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; OSTEOCALCIN; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN N PROTEINASE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOREARM; HUMAN; HUMAN EXPERIMENT; POSTMENOPAUSE OSTEOPOROSIS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; COHORT STUDIES; COLLAGEN; COLLAGEN TYPE I; FEMALE; FOREARM; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES;

EID: 0032880585     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.9.1614     Document Type: Article

References (32)

1. Cummings SR, Nevitt MC, Bowner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. N Engl J Med 332:767-773.
2. Melton U, IIIAtkinson EJ, O'Fallon WM, Wahner HW, Riggs BL 1993 Long-term fracture prediction by bone mineral density assessed at different skeletal sites. J Bone Miner Res 8:1227-1233.
3. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt T 1993 Bone density at various sites for prediction of hip fractures. Lancet 341:72-75.
4. Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C 1996 Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15 year follow-up study. Bone 19:9-12.
5. Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL 1983 Increase in serum bone gamma carboxyglutamic acid protein with aging in women. J Clin Invest 71:1316-1421.
6. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD 1996 Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 3:337-349.
7. Eastell R 1996 Assessment of bone density and bone loss. Osteoporos Int 6:S36-S37.
8. Christiansen C, Riis BJ, Rodbro P 1987 Prediction of rapid bone loss in postmenopausal women. Lancet 1:1105-1108.
9. Johansen JS, Riis BJ, Delmas PD, Christiansen C 1988 Plasma BGP: An indicator of spontaneous bone loss and effect of estrogen treatment in postmenopausal women. Eur J Clin Invest 18:191-195.
10. Uebelhart D, Schlemmer A, Johansen J, Gineyts E, Christiansen C, Delmas PD 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab 72:367-373.
11. Hansen MA, Kirsten O, Riss BJ, Christiansen C 1991 Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 years study. BMJ 303:961-964.
12. Pouillès JM, Trémollières F, Ribot C 1993 Is it possible to identify women with accelerated vertebral bone loss? Results of a longitudinal study in ninety-two recently postmenopausal women. Rev Rheum (Engl) 60:186-191.
13. Keen RW, Nguyen T, Sobnack R, Perry LA, Thompson PW, Spector TD 1996 Can biochemical markers predict bone loss at the hip and spine? A 4-year prospective study of 141 early postmenopausal women. Osteoporos Int 6:399-406.
14. Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL 1996 Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int 59:328-333.
15. Ross PD, Knowlton W 1998 Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 13:297-302.
16. Schlesselman JJ 1973 Planning a longitudinal study. II. Frequency of measurement and study duration. J Chron Dis 26:561-570.
17. Garnero P, Grimaux M, Seguin P, Delmas PD 1994 Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 9:255-264.
18. Garnero P, Delmas PD 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:1046-1053.
19. Winterbottom N, Vernon S, Freeman K, Daniloff G, Seyedin S 1993 A serum immunoassay for the C-terminal propeptide of type I collagen. J Bone Miner Res 8 (Suppl 1):S341.
20. Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, Risteli J 1996 Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 46:947-954.
21. Hanson DA, Weiss MAE, Bollen AM, Maslan SL, Singer FR, Eyre DR 1992 A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1251-1258.
22. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C 1994 Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:2022-2025.
23. Garnero P, Gineyts E, Riou JP, Delmas PD 1994 Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone diseases. J Clin Endocrinol Metab 79:780-785.
24. Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, Christiansen C 1998 Serum Crosslaps one step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 44:2281-2289.
25. Nguyen TV, Sambrook PN, Eisman JA 1997 Sources of variability in bone mineral density measurements: Implications for study design and analysis of bone loss. J Bone Miner Res 12:124-135.
26. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC 1996 Sex steroids, bone mass, and bone loss: A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 97:14-21.
27. Bollen A-M, Martin MD, Leroux BG, Eyre DR 1995 Circadian variation in urinary excretion of bone collagen crosslinks. J Bone Miner Res 10:1885-1889.
28. Oshima H, Kushida K, Takahashi M, et al. 1998 Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide bound forms of pyridinium crosslinks. Bone 22:73-78.
29. Garnero P, Hausherr E, Chapuy M-C, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture risk in elderly women: The EPIDOS Prospective Study. J Bone Miner Res 11:1531-1538.
30. van Daele PLA, Seibel MJ, Burger H, Hofman A, Grobbee DE, van Leeuwen JP, Birkenhager JC, Pols HA 1996 Casecontrol analysis of bone resorption markers, disability, and hip fracture: the Rotterdam study. BMJ 312:482-483.
31. van Daele PLA, Seibel MJ, Burger H, De Laet CEDH, van Leeuwen JPTM, Hofman A, Birkenhäger JC, Pols HAP 1996 Evidence for uncoupling of bone formation and bone resorption in women with hip fractures: A prospective study. Osteoporos Int 6 (Suppl 1):199.
32. Marshall D, Johnell O, Wedel H 1996 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254-1259.